Progressive CT abnormalities despite clinical improvement in SSPE treated with inosiplex
- 1 April 1983
- journal article
- case report
- Published by Wiley in Annals of Neurology
- Vol. 13 (4) , 457-460
- https://doi.org/10.1002/ana.410130416
Abstract
Inosiplex has been utilized in the treatment of subacute sclerosing panencephalitis (SSPE), though without unequivocally established beneficial effect. We report a patient whose computerized tomographic (CT) scans demonstrated the development of progressive cerebral atrophy and multifocal white matter lesions despite continuous treatment with inosiplex and periods of considerable clinical improvement or stabilization. The findings suggest that inosiplex may not have altered the pathological consequences of SSPE and that clinical staging categories alone may not be reliable long‐term correlates of the progression of the disease. Controlled studies utilizing assessment of brain mass by CT scan or other imaging devices in addition to clinical staging are required to evaluate the efficacy of inosiplex.Keywords
This publication has 14 references indexed in Scilit:
- Long‐term follow‐up of patients with subacute sclerosing panencephalitis treated with inosiplexAnnals of Neurology, 1982
- Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: A controlled studyAnnals of Neurology, 1980
- The Variable Natural History of Subacute Sclerosing PanencephalitisArchives of Neurology, 1979
- Isoprinosine in subacute sclerosing panencephalitisNeurology, 1979
- Inosiplex in the Treatment of Subacute Sclerosing PanencephalitisArchives of Neurology, 1979
- Subacute schlerosing panencephalitis in the middle east: Report of 99 casesAnnals of Neurology, 1977
- Subacute sclerosing panencephalitis as a cause of chronic dementia and relapsing brain disorderJournal of Neurology, Neurosurgery & Psychiatry, 1972
- Non-fatal subacute sclerosing leucoencephalitis.Journal of Neurology, Neurosurgery & Psychiatry, 1968
- Treatment of subacute sclerosing panencephalitis with 5‐bromo‐2‐deoxyuridine and pyran copolymerNeurology, 1968
- Relapsing inclusion encephalitis (Dawson type) of eight years' durationNeurology, 1958